Reduced Initial TKI Dose Comparable to Full Dose in Metastatic Renal Cell Carcinoma
Researchers sought to determine if reducing the starting dose of TKI therapy in patients with metastatic RCC would improve tolerability without reducing efficacy.
Kidney Cancer
Kidney Failure Risk Higher After Kidney Cancer Surgery
Investigators report a cumulative 10-year incidence of end-stage kidney disease of 2.5% among patients who undergo surgery for renal cell carcinoma (RCC), which is 10 times higher than in patients without RCC.
Obesity Is Associated With Increased Risk for Renal Cell Carcinoma
New findings challenge the notion of an obesity paradox with regard to cancer-related survival.
Imaging Response to Immunotherapy Combination Therapies in mRCC
Investigators report findings from the largest analysis characterizing objective imaging response among patients with mRCC treated in routine clinical practice.
Dialysis Population Has Excess Cancer Mortality
Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Kidney Cancer Metastases Effectively Treated With Robotic Radiosurgery
Investigators examined outcomes of robotic radiosurgery in patients with lung, visceral, and lymph node metastases from renal cell carcinoma.
Trials Investigating Bempegaldesleukin in Combination With Nivolumab Discontinued
The decision to discontinue was based on data from pre-planned analyses of the phase 3 PIVOT-09 study and the phase 2 PIVOT-10 study.
Cancer Is Associated With Increased Kidney Failure Risk
The risk for kidney failure requiring renal replacement therapy varies by cancer type, with multiple myeloma associated with the highest risk.
Updates in the Management of Urologic Cancers
Several guidelines outline best practice for monitoring patients receiving immune checkpoint inhibitors, how to detect the early signs of these adverse events, and how to manage the events.
Minimally Invasive Partial Nephrectomy Does Not Worsen Cancer Outcomes
A minimally invasive approach does not increase risk for atypical sites of kidney cancer recurrence, a recent study suggests.
- Loading...
Loading...
Next post in Kidney Cancer
Loading... 
Loading...